艾欧凡斯生物治疗 IOVA
$8.04 +$0.30 (+3.88%)
休市 · Nov 7, 10:00 pm ET · 最新盘后价 $8.05 +0.07%
开盘$8.10
昨收$7.74
当日区间$7.72 – $8.28
成交量12.96M
市值$3.72B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例64.3%+0.56 个百分点，较上季度
持仓机构数337+4 ，较上季度
内部人近期交易32次买入 / 18次卖出净买入
空头持仓比例13.01% 占流通股回补天数 4.4 · 截至 15 Oct 2026
卖空成交量占比12.2%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$26.02M（5个净流入日，15个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有30.7%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从22.39%降至13.01%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +2,578,238 | 0.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +7,030,160 | 5.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +5,877,176 | 8.2% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +5,323,264 | 4.2% |
| Jupiter Fund Management Plc | Mutual Fund | 2026/Q3 | +4,535,080 | 1.0% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +3,814,747 | 1.4% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +3,234,434 | 0.8% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +2,688,155 | 3.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,945,091 | 4.6% |
| Xcelsior Advisor Partners LLC | Mutual Fund | 2026/Q3 | +1,769,774 | 0.4% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,752,228 | 2.3% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +1,702,617 | 0.6% |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Mutual Fund | 2026/Q3 | +1,397,235 | 1.1% |
| FMR | Mutual Fund | 2026/Q3 | +1,304,086 | 0.3% |
| Northern Trust Global Investments | Mutual Fund | 2026/Q3 | +1,278,674 | 0.9% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 29 Sep 2026 | Noah Berkowitz | Chief Medical Officer | Other Derivative Acquisition | +135,000 | $14.82 | 135,000 |
| 29 Sep 2026 | Noah Berkowitz | Chief Medical Officer | Other Derivative Acquisition | +180,000 | – | 180,000 |
| 7 Sep 2026 | Igor Bilinsky | Chief Operating Officer | Derivative Exercise and Sale | -3,976 | $8.70 | 142,074 |
| 7 Sep 2026 | Igor Bilinsky | Chief Operating Officer | Derivative Exercise and Retained | +3,837 | – | 142,074 |
| 7 Sep 2026 | Frederick Vogt | Interim CEO, President, General Counsel, Corporate Secretary & Director | Derivative Exercise and Sale | -6,638 | $8.70 | 595,447 |
| 7 Sep 2026 | Frederick Vogt | Interim CEO, President, General Counsel, Corporate Secretary & Director | Derivative Exercise and Retained | +8,988 | – | 595,447 |
| 7 Sep 2026 | Raj Puri | Chief Regulatory Officer | Derivative Exercise and Sale | -4,478 | $8.70 | 256,364 |
| 7 Sep 2026 | Raj Puri | Chief Regulatory Officer | Derivative Exercise and Retained | +5,288 | – | 256,364 |
| 31 Aug 2026 | Igor Bilinsky | Chief Operating Officer | Derivative Exercise and Sale | -4,472 | $8.28 | 138,237 |
| 31 Aug 2026 | Igor Bilinsky | Chief Operating Officer | Derivative Exercise and Retained | +4,317 | – | 138,237 |
| 31 Aug 2026 | Frederick Vogt | Interim CEO, President, General Counsel, Corporate Secretary & Director | Derivative Exercise and Sale | -17,702 | $8.28 | 586,459 |
| 31 Aug 2026 | Frederick Vogt | Interim CEO, President, General Counsel, Corporate Secretary & Director | Derivative Exercise and Retained | +23,967 | – | 586,459 |
| 31 Aug 2026 | Raj Puri | Chief Regulatory Officer | Derivative Exercise and Sale | -2,508 | $8.28 | 251,076 |
| 31 Aug 2026 | Raj Puri | Chief Regulatory Officer | Derivative Exercise and Retained | +2,962 | – | 251,076 |
| 9 Aug 2026 | Daniel Kirby | Chief Commercial Officer | Derivative Exercise and Sale | -2,436 | $6.40 | 154,511 |
| 9 Aug 2026 | Daniel Kirby | Chief Commercial Officer | Derivative Exercise and Retained | +7,565 | – | 154,511 |
| 5 Aug 2026 | Corleen Roche | Chief Financial Officer | Derivative Exercise and Sale | -21,238 | $6.21 | 28,757 |
| 5 Aug 2026 | Corleen Roche | Chief Financial Officer | Derivative Exercise and Retained | +28,757 | – | 28,757 |
| 15 Jun 2026 | Michael Weiser | Independent Director | Other Derivative Acquisition | +90,316 | – | 90,316 |
| 15 Jun 2026 | Ryan Maynard | Independent Director | Other Derivative Acquisition | +90,316 | – | 90,316 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 58,925,298 | 13.0% | 4.4 |
| 30 Sep 2026 | 64,827,030 | 14.3% | 2.8 |
| 15 Sep 2026 | 87,127,871 | 19.2% | 7.4 |
| 31 Aug 2026 | 88,138,991 | 19.5% | 5.3 |
| 14 Aug 2026 | 102,940,590 | 22.7% | 4.8 |
| 31 Jul 2026 | 99,975,709 | 22.4% | 6.3 |
暂无评论——快来第一个聊聊 IOVA。
登录后参与讨论。